Mma-pahero.com

Mma-pahero.com has Server used 208.75.148.200 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2021-06-29 (0 years, 333 days) and hosted in Chicago United States, server ping response time 62 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Mma-pahero keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Mapa heroiny
2 Mapa herobrine
3 Mapa herodota
4 Mapa heroes 3
5 Mapa heroquest
6 Mapa hero base
7 Mapa herosa tv do ls19
8 Mma parow
9 Mapa heroes tecamac

Hosting Provider

Website: Mma-pahero.com
Hostname: host.mytechtailor.com
Country:
NetName:
Address: 4210 Creyts Rd.,
Region: IL
City: Chicago
Postal Code: 60604
Latitude: 41.877601623535
Longitude: -87.627197265625
Area Code: 312
Email Abuse1. [email protected]
2. [email protected]

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Revo.com (4 day ago)

   » Bobbyjonesband.com (10 hours ago)

   » 1stchoiceautosllc.com (1 hours ago)

   » Huishoubao.com (8 hours ago)

   » M1file.com (21 hours ago)

   » Renhomesantalya.com (18 hours ago)

   » Napadrivertours.com (20 hours ago)

Results For Websites Listing

Found 9 Websites with content related to this domain, It is result after search with search engine

Mma-pahero.com   DA: 14 PA: 14 MOZ Rank: 28

  • HemoShear’s drug HST5040 is designed to correct metabolic abnormalities associated with MMA and PA
  • HST5040 may distribute to multiple affected tissues and may have the potential to be active throughout the body, including the kidney, liver, brain, heart and muscles
  • Assessing the safety of HST5040 in MMA and PA patients is a critical

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 69

  • More information can be found at www.MMA-PAHero.com or ClinicalTrials.gov (NCT04732429)
  • Methylmalonic acidemia (MMA) and propionic acidemia (PA) are rare genetic disorders

Mma-paimpact.com   DA: 16 PA: 16 MOZ Rank: 34

  • The Impact Study is being conducted to understand what day-to-day life is like for people with methylmalonic acidemia (MMA) and propionic acidemia (PA) as well as for parents or caregivers
  • These diseases can impact many aspects of life – how you feel, what you can do, and how you relate to others
  • Volunteers for this study will be given the opportunity to share their range of …

Checkrare.com   DA: 13 PA: 50 MOZ Rank: 66

  • Patrick Horn, MD, PhD, Chief Medical Officer at HemoShear Therapeutics, discusses the phase 2 HERO trial evaluating HST5040 in patients with methylmalonic acidemia (MMA) and propionic acidemia (PA).
  • MMA and PA are rare inherited metabolic disorders in which the body is unable to process certain proteins and lipids properly.

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 71

  • MMA and PA are diagnosed through newborn screening in the United States and in select countries in Europe, the Middle East and the rest of the world
  • The diseases result in the buildup of toxic

Ncbi.nlm.nih.gov   DA: 20 PA: 25 MOZ Rank: 50

  • Clinical Presentation, Diagnosis, and Management
  • PA and MMA classically present in a term neonate within the first 3 days of life, who feeds poorly, is pancytopenic, becomes progressively encephalopathic, and ultimately progresses to coma and death without prompt identification and management [22, 37–44].The differential diagnosis in this age group includes sepsis, hypoxic …

Vabio.org   DA: 13 PA: 50 MOZ Rank: 69

  • More information can be found at www.MMA-PAHero.com or ClinicalTrials.gov (NCT04732429)
  • “This is a tremendous milestone for patients and families who desperately need a treatment that can potentially target all organs affected by these diseases,” said Jim Powers, Chairman and CEO of HemoShear
  • “We named this the HERO study because of the

Hemoshear.com   DA: 13 PA: 50 MOZ Rank: 70

  • More information can be found at www.MMA-PAHero.com or ClinicalTrials.gov (NCT04732429)
  • “This is a tremendous milestone for patients and families who desperately need a treatment that can potentially target all organs affected by these diseases,” said Jim Powers, Chairman and CEO of HemoShear
  • “We named this the HERO study because of the

Biospace.com   DA: 16 PA: 50 MOZ Rank: 74

  • More information can be found at www.MMA-PAHero.com or ClinicalTrials.gov (NCT04732429)
  • "This is a tremendous milestone for patients and families who desperately need a treatment that can potentially target all organs affected by these diseases," said Jim Powers, Chairman and CEO of HemoShear
  • "We named this the HERO study because of the

Recently Analyzed Sites

Revo.com (4 day ago)

Bobbyjonesband.com (10 hours ago)

1stchoiceautosllc.com (1 hours ago)

Huishoubao.com (8 hours ago)

M1file.com (21 hours ago)

Renhomesantalya.com (18 hours ago)

Napadrivertours.com (20 hours ago)

Trekksoft.com (19 hours ago)

Tibbo.com (13 day ago)

Adottauncane.net (1 min ago)

Tailspinbandsc.com (18 hours ago)

Dungscanada.com (3 day ago)

Jfsorange.org (18 hours ago)

Marloweslu.com (1 day ago)